Regenerative Therapies: Platelet-Rich Plasma Therapy: An Answer to Joint Pain

Wednesday 30 July 2014

Platelet-Rich Plasma Therapy: An Answer to Joint Pain



Platelet-Rich Plasma Therapy

Platelet-Rich Plasma (PRP) therapy is widely acknowledged by doctors across the world. This therapy is suggested to people who are suffering from acute ACL, MCL, Meniscus, and Tendon injuries at different body parts including hip, knees, shoulders, ankles, elbows, and back. 


Many a time, we see the sportsperson developing acute pain in the cartilage and muscles. They visit different healthcare clinics to receive the best treatment to quickly heal their damage. However, the traditional treatment procedure calls for a surgery which is not only costly but also the patient has no other option left than to lie on bed for days and even months to recover post-surgery.

The Treatment Procedure

One of the highly advanced methods for treating these kinds of physical problems and discomfort is the Platelet-Rich Plasma therapy. During the treatment phase, certified doctors take a small portion of blood from a patient’s body and separate the platelet-rich plasma from the other elements found in the human blood. Then the doctor offering PRP therapy in Seattle or any other region in USA injects the concentrated platelets into the damaged area to help him or her recover instantly. On the same day, itself the patient is free to go home. 

Benefits of Platelet-Rich Plasma Treatment

One of the main benefits of platelet-rich plasma treatment is that it is minimally invasive. The patient does not have to undergo a costly surgery or spend time in the hospital for recovering from a surgery.  Any kind of hip, knee, or ankle injury, muscle and joint pain can be healed through PRP injections given by experienced doctors of USA

Skin PRP Cell Injection

Damaged skin can also be restored via PRP cell treatment where cosmetic fillers are used for complete skin transformation for the better. A person will look younger and beautiful after PRP cell injection.

No comments:

Post a Comment